Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Bacterial Infections
Related studies linked through entity extraction aliases.
Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance
- Status
- COMPLETED
- Phase
- N/A
Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Complication Rates Associated With PICC for Left vs Right
- Status
- COMPLETED
- Phase
- NA
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Hospital Wide Roll-Out of Antimicrobial Stewardship
- Status
- COMPLETED
- Phase
- NA
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Xylitol on Oral Microbiota in Children
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
- Status
- COMPLETED
- Phase
- PHASE3
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Doripenem in Infants Less Than 12 Weeks of Age
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)
- Status
- COMPLETED
- Phase
- PHASE3